Scope of the Study
According to the American Hair Loss Association, androgenetic alopecia accounts for over 95% of hair loss in men. Alopecia is a term that refers to excessive hair damage under certain medical conditions or dietary issues. Factors like sedentary lifestyle, and unhealthy diets are a leading to loss of hair among people. Further, ageing and hormonal imbalance, increasing chronic disease like arthritis, cancer, hypertension, depression also leads to hair loss are driving the Global Alopecia Market.
The market study is being classified by Type (Oral treatment, Topical treatment and Other treatment), by Application (Homecare Settings, Dermatology Clinics and Others (Salons)) and major geographies with country level break-up. According to AMA, the Global Alopecia market is expected to see growth rate of 6.92%
Lifes2good (Ireland), Kirkland Signature (United States), Johnson & Johnson Services (United States), Dr. Reddy's Laboratories (India), Cipla Inc.(India), Alpecin (Germany), Vitabiotics Ltd. (United Kingdom), Sun Pharmaceuticals Industries Ltd. (India) and Phyto Ales Group (France) are some of the key players profiled in the study.
The market is fragmented with numerous players who continuously involved in identifying Drugs and Treatment for Alopecia. The large populations suffering from Alopecia and the rising awareness levels pertaining to the available therapeutic options are driving the market. Further intensive research activities towards introducing innovative treatment options and growth in disposable incomes of the general population will allow significant growth of this market. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Alopecia market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Alopecia market by Type, Application and Region.
On the basis of geography, the market of Alopecia has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Asia Pacific on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Treatment, the sub-segment i.e. Vitamins and Supplements will boost the Alopecia market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Gender, the sub-segment i.e. Male will boost the Alopecia market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Level of Genetic Disorders, Air and Water Pollution
- Rising Healthcare Expenditure
- Effective Treatment Option for Hair Treatment & its Awareness
- Demand for Alopecia Treatment in Developing Countries
- Changing Lifestyle of People
- Growing Geriatric Population Undergoing Alopecia Treatment
- Probable Side Effects and Allergies Caused due to Alopecia Treatment
- Increasing R & D Investment For Hair Loss Treatment
- Demand for Surgical Hair Transplant
- Cost Factor Associated with the Alopecia Treatment
July 2018, The Bald Truth was launched which is a weekly online streamed radio show hosted by Spencer Kobren, founder and president of the American Hair Loss Association., A radio program involved in spreading awareness about the different types of alopecia affecting people and about the varied products used for the effective treatment of alopecia that is currently available in the market. and November 2018, Sammued LLC Company announced the first subject dose in Phase 2/3 trial of SM04554, a topical small molecule Wnt pathway activator which specifically stimulates hair growth in men and women.
July 2018, The Food and Drug Administration (FDA) approves of the Janus kinase inhibitors (JAK) drugs that stimulate the growth of hair follicles with minimal side effects.
Key Target Audience
Alopecia Drugs Manufacturers, Traders/Distributors/Dealers/Suppliers, Potential Investors, Downstream Vendors, Hair Transplant Clinics, Private Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers, Government Research Laboratories and Contract Manufacturing Organizations
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase